BSEBoard Meetingboard_meeting2d ago
Aptus Pharma Ltd
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Prior Intimation of Board Meeting ....
Aptus Pharma Ltd has informed BSE that a meeting of the Board of Directors is scheduled on August 17, 2026, to consider and approve prior intimation of the board meeting, including the valuation report for a preferential issue, determination of issue price, and convening of the 16th Annual General Meeting.
BSECompany Update4d ago
Aptus Pharma Ltd
Please find attached Clarification letter in respect of Outcome of Board meeting held on 08.08.2026 and submitted on 08.08.2026 for approval of Preferential issue of Shares
Aptus Pharma Ltd has issued a clarification regarding typographical errors in its board meeting outcome announcement, stating that the errors are purely typographical and do not change the substance or outcome of the resolutions passed.
BSEBoard MeetingFundraise6d ago
Aptus Pharma Ltd
please find attached outcome of board meeting dated 08.08.2026 for approval of preferential issue of shares
Aptus Pharma Ltd has announced the outcome of its board meeting, where it approved the preferential issue of 16,10,100 equity shares at a price to be determined by a registered valuer. The company also fixed the date of its annual general meeting for September 14, 2026. The preferential issue is subject to the approval of the shareholders and other necessary approvals.
BSEBoard MeetingFundraise5 Aug 2026
Aptus Pharma Ltd
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Aptus Pharma Ltd has informed BSE that a Board Meeting is scheduled on August 8, 2026, to consider raising funds through a preferential allotment of equity shares and to announce the closure of the trading window.